Diabetes mellitus and the benefit of antiresorptive therapy on fracture risk. Eastell R, Vittinghoff E, Lui LY, Ewing SK, et al. J Bone Miner Res 2022 Sep 6. doi: 10.1002/jbmr.4697.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Eastell R, Vittinghoff E, Lui LY, Ewing SK, et al. Diabetes mellitus and the benefit of antiresorptive therapy on fracture risk. J Bone Miner Res 2022 Sep 6. doi: 10.1002/jbmr.4697.
PMID: 36065588